Wellington Management Group
EW icon

Wellington Management Group’s Edwards Lifesciences EW Stock Holding History

Wellington Management Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.76B Buy
22,011,101
+217,152
+1% +$17.9M 0.33% 68
2025
Q4 		$1.86B Buy
21,793,949
+989,533
+5% +$81.2M 0.33% 70
2025
Q3 		$1.62B Buy
20,804,416
+977,933
+5% +$76.4M 0.28% 78
2025
Q2 		$1.55B Sell
19,826,483
-9,308,307
-32% -$694M 0.28% 84
2025
Q1 		$2.11B Sell
29,134,790
-4,076,089
-12% -$292M 0.41% 63
2024
Q4 		$2.46B Buy
33,210,879
+1,678,154
+5% +$117M 0.45% 51
2024
Q3 		$2.08B Buy
31,532,725
+14,610,123
+86% +$1.06B 0.36% 67
2024
Q2 		$1.56B Buy
16,922,602
+1,372,843
+9% +$122M 0.28% 85
2024
Q1 		$1.49B Sell
15,549,759
-1,277,751
-8% -$107M 0.26% 98
2023
Q4 		$1.28B Buy
16,827,510
+393,109
+2% +$27.4M 0.24% 109
2023
Q3 		$1.14B Buy
16,434,401
+1,390,427
+9% +$112M 0.23% 110
2023
Q2 		$1.42B Sell
15,043,974
-806,081
-5% -$70.1M 0.27% 93
2023
Q1 		$1.31B Buy
15,850,055
+578,319
+4% +$45.5M 0.26% 98
2022
Q4 		$1.14B Buy
15,271,736
+624,619
+4% +$48.1M 0.23% 106
2022
Q3 		$1.21B Buy
14,647,117
+468,181
+3% +$45M 0.26% 98
2022
Q2 		$1.35B Sell
14,178,936
-814,587
-5% -$84.3M 0.27% 90
2022
Q1 		$1.77B Sell
14,993,523
-606,517
-4% -$68M 0.3% 79
2021
Q4 		$2.02B Sell
15,600,040
-789,362
-5% -$92.1M 0.32% 74
2021
Q3 		$1.86B Sell
16,389,402
-354,990
-2% -$40.5M 0.32% 79
2021
Q2 		$1.73B Buy
16,744,392
+212,898
+1% +$20.1M 0.29% 87
2021
Q1 		$1.38B Sell
16,531,494
-1,755,608
-10% -$148M 0.24% 99
2020
Q4 		$1.67B Sell
18,287,102
-1,940,078
-10% -$161M 0.31% 78
2020
Q3 		$1.61B Sell
20,227,180
-420,570
-2% -$32.8M 0.33% 77
2020
Q2 		$1.43B Buy
20,647,750
+1,435,096
+7% +$102M 0.32% 76
2020
Q1 		$1.21B Buy
19,212,654
+5,822,223
+43% +$420M 0.32% 78
2019
Q4 		$1.04B Buy
13,390,431
+563,508
+4% +$44M 0.22% 106
2019
Q3 		$940M Sell
12,826,923
-1,603,167
-11% -$113M 0.21% 110
2019
Q2 		$889M Sell
14,430,090
-4,864,119
-25% -$294M 0.2% 121
2019
Q1 		$1.23B Sell
19,294,209
-3,750,702
-16% -$214M 0.28% 94
2018
Q4 		$1.18B Buy
23,044,911
+2,696,406
+13% +$136M 0.29% 88
2018
Q3 		$1.18B Buy
20,348,505
+1,324,626
+7% +$64.8M 0.25% 105
2018
Q2 		$923M Buy
19,023,879
+252,222
+1% +$11.8M 0.21% 124
2018
Q1 		$873M Sell
18,771,657
-897,789
-5% -$39M 0.2% 125
2017
Q4 		$739M Buy
19,669,446
+2,568,921
+15% +$94.3M 0.16% 153
2017
Q3 		$623M Buy
17,100,525
+532,392
+3% +$20.3M 0.14% 168
2017
Q2 		$653M Sell
16,568,133
-2,718,441
-14% -$99.2M 0.15% 153
2017
Q1 		$605M Sell
19,286,574
-696,258
-3% -$21.8M 0.15% 165
2016
Q4 		$624M Buy
19,982,832
+8,870,070
+80% +$287M 0.16% 151
2016
Q3 		$447M Buy
11,112,762
+4,009,497
+56% +$151M 0.11% 190
2016
Q2 		$236M Sell
7,103,265
-1,017,129
-13% -$34.8M 0.06% 279
2016
Q1 		$239M Sell
8,120,394
-12,553,188
-61% -$346M 0.06% 275
2015
Q4 		$544M Sell
20,673,582
-5,339,748
-21% -$139M 0.14% 149
2015
Q3 		$616M Sell
26,013,330
-6,686,778
-20% -$161M 0.17% 132
2015
Q2 		$776M Buy
32,700,108
+11,163,480
+52% +$252M 0.2% 116
2015
Q1 		$511M Buy
21,536,628
+10,116
+0% +$227K 0.13% 158
2014
Q4 		$457M Sell
21,526,512
-4,446,510
-17% -$89.3M 0.12% 168
2014
Q3 		$442M Sell
25,973,022
-3,746,178
-13% -$59.1M 0.12% 180
2014
Q2 		$425M Sell
29,719,200
-2,224,800
-7% -$30.2M 0.11% 192
2014
Q1 		$395M Sell
31,944,000
-1,443,000
-4% -$16.7M 0.11% 205
2013
Q4 		$366M Buy
33,387,000
+23,949,156
+254% +$270M 0.11% 218
2013
Q3 		$110M Buy
9,437,844
+1,570,908
+20% +$18.4M 0.03% 471
2013
Q2 		$88.1M Buy
+7,866,936
New +$93.1M 0.03% 508

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Wellington Management Group's EW Position: Q1 2026 in Review

Wellington Management Group increased its Edwards Lifesciences (EW) stake by 1% in Q1 2026, buying an estimated $17.9M and bringing the position to 22,011,101 shares worth $1.76B. The position accounts for 0.33% of the portfolio, ranked #68.

Wellington Management Group first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.46B in Q4 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Wellington Management Group held 22,011,101 shares of Edwards Lifesciences worth $1.76B as of Q1 2026.
  • Wellington Management Group bought 217,152 Edwards Lifesciences shares in Q1 2026, an estimated $17.9M.
  • Edwards Lifesciences made up 0.33% of Wellington Management Group's portfolio in Q1 2026, its #68 holding.
  • Wellington Management Group first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
  • Wellington Management Group's Edwards Lifesciences position peaked at $2.46B in Q4 2024.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.